Global IV Tubing Sets & Accessories Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Primary IV Tubing Sets, Secondary IV Tubing Sets, IV Tubing Accessories, Extension IV Tubing Sets, and Others.By Application;
Central Venous Catheter Placemen, Peripheral Intravenous Catheter Insertion, and PICC Line Insertion.By End User;
Hospitals, Ambulatory Surgical Centers, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global IV Tubing Sets & Accessories Market (USD Million), 2021 - 2031
In the year 2024, the Global IV Tubing Sets & Accessories Market was valued at USD 1,153.91 million. The size of this market is expected to increase to USD 1,518.47 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.0%.
Global IV Tubing Sets & Accessories Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 4.0 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 4.0 % |
Market Size (2024) | USD 1,153.91 Million |
Market Size (2031) | USD 1,518.47 Million |
Market Concentration | High |
Report Pages | 395 |
Major Players
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius Kabi AG
- Smiths Medical
- ICU Medical, Inc.
- Nipro Corporation
- Terumo Corporation
- Vygon Group
- Poly Medicure Limited
- Zyno Medical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global IV Tubing Sets & Accessories Market
Fragmented - Highly competitive market without dominant players
The global IV tubing sets and accessories market is witnessing consistent growth due to the escalating need for accurate and reliable intravenous therapy in clinical settings. These medical devices are vital for delivering fluids, nutrients, and medications directly into the bloodstream, especially in patients with chronic conditions. As hospitalization rates rise, the demand for high-performance IV systems is growing steadily, with the market expanding at an annual rate exceeding 6%.
Technology-Driven Enhancements in IV Systems
The industry is rapidly evolving with the integration of advanced features such as smart tubing systems and needleless connectors, aimed at enhancing user safety and minimizing contamination risks. Notably, approximately 30% of new product developments are focused on reducing manual errors and improving operational efficiency, aligning with the healthcare sector's increasing shift toward automation and digital integration.
Infection Control as a Market Catalyst
A heightened emphasis on infection prevention is a key factor fueling market momentum. Healthcare providers are increasingly adopting IV accessories equipped with antimicrobial coatings and anti-reflux valves, helping to reduce hospital-acquired infections. Currently, nearly 40% of healthcare facilities have implemented these advanced systems to comply with evolving safety standards and enhance patient outcomes.
Customization and Economic Viability Driving Adoption
Flexibility and cost-efficiency are emerging as critical purchase drivers for IV tubing systems. Around 50% of healthcare institutions are prioritizing tubing sets that are not only budget-friendly but also adaptable to various infusion pumps and therapies. The rise of customized tubing kits tailored to specific clinical procedures is helping improve workflow efficiency and patient care precision.
Infrastructure Investment Boosting Market Expansion
Ongoing investments in medical infrastructure and healthcare delivery systems are fostering the growth of the IV tubing and accessories market. With funding in patient safety tools rising by over 35%, institutions are increasingly focusing on equipment that improves treatment outcomes and operational safety. This investment trend is setting the stage for sustained market development in the coming years.
Global IV Tubing Sets & Accessories Market Recent Developments
-
In September 2022, the Association for Vascular Access (AVA) joined forces with B. Braun to launch the Fundamentals of Peripheral IV Access eLearning Program. This collaborative initiative aims to elevate the quality and consistency of peripheral IV access education across healthcare institutions. By targeting medical schools and hospitals, the program seeks to improve clinical competency, reduce complications, and promote best practices in IV therapy. The effort underscores the growing emphasis on standardizing vascular access training to enhance patient safety and care outcomes.
-
In June 2022, B. Braun Medical Inc. introduced the Introcan Safety 2 IV Catheter, a next-generation device featuring one-time blood control technology. This advancement is specifically designed to enhance clinician safety by significantly reducing the risk of needlestick injuries and limiting exposure to blood during IV insertion. The catheter integrates seamlessly into existing clinical workflows while prioritizing protection and patient care. This launch highlights B. Braun’s continued commitment to developing safety-focused innovations in vascular access.
Segment Analysis
In this report, the Global IV Tubing Sets & Accessories Market has been segmented by Product, Application, End User, and Geography.
Global IV Tubing Sets & Accessories Market, Segmentation by Product
The Global IV Tubing Sets & Accessories Market has been segmented by Product into Primary IV Tubing Sets, Secondary IV Tubing Sets, IV Tubing Accessories, Extension IV Tubing Sets, and Others.
Primary IV Tubing Sets
Primary IV tubing sets dominate the global market, contributing approximately 45–50% to the overall share. These sets are widely used for continuous intravenous medication and fluid administration in both inpatient and outpatient settings. Their high demand is fueled by the rising number of hospital admissions, chronic disease treatments, and surgical interventions. With consistent usage across healthcare facilities, this segment remains the backbone of IV therapy solutions.
Secondary IV Tubing Sets
Holding around 15–20% of the market, secondary IV tubing sets are essential for administering additional medications without interrupting the primary infusion. Commonly used in combination drug therapies, they enhance treatment efficiency and reduce the risk of infection. Their growing adoption, especially in ambulatory care and infusion clinics, reflects the increasing focus on cost-effective and safe medication delivery systems.
IV Tubing Accessories
Accounting for nearly 10–12% of the market, IV tubing accessories—such as filters, connectors, spikes, and clamps—play a crucial role in ensuring secure and sterile IV administration. The demand for these components is steadily rising due to heightened awareness of infection prevention and the need for reliable IV system customization. They are indispensable in modern IV setups, supporting both functionality and patient safety.
Extension IV Tubing Sets
Extension IV tubing sets represent about 8–10% of the market and are primarily used to extend the reach of IV lines in critical care or complex procedural settings. Their value lies in offering flexibility, especially in scenarios requiring multiple access points or limited patient mobility. With the rise in home healthcare services and ICU admissions, this segment is seeing increased demand due to its practical advantages in patient management.
Others
The 'Others' category, comprising 5–7% of the market, includes specialized IV tubing sets tailored for niche applications such as neonatal, pediatric, or oncology care. Though smaller in scale, this segment is gaining traction due to advancements in patient-specific drug delivery technologies. As personalized medicine grows, demand for these customized IV solutions is expected to rise steadily.
Global IV Tubing Sets & Accessories Market, Segmentation by Application
The Global IV Tubing Sets & Accessories Market has been segmented by Application into Central Venous Catheter Placemen, Peripheral Intravenous Catheter Insertion, and PICC Line Insertion.
Central Venous Catheter Placement
Central venous catheter placement makes up approximately 40–45% of the global application market. This procedure is essential in intensive care units (ICUs) for delivering long-term intravenous treatments such as chemotherapy, antibiotics, and parenteral nutrition. Its increasing use is driven by a rise in critical care admissions and patients with complex chronic illnesses requiring advanced vascular access.
Peripheral Intravenous Catheter Insertion
Peripheral intravenous catheter insertion accounts for about 35–40% of the market and is the most commonly performed IV access method. Known for its simplicity, cost-effectiveness, and low complication rates, it is widely used in emergency care and short-term treatments. The growth of this segment is fueled by the expanding number of outpatient procedures and hospital admissions globally.
PICC Line Insertion
PICC line insertion captures roughly 15–20% of the market and is favored for mid- to long-term IV therapy needs. It plays a vital role in treating patients with cancer, infections, and those undergoing home healthcare. Its increasing popularity stems from reduced needle stick injuries and enhanced patient comfort during prolonged treatment cycles.
Global IV Tubing Sets & Accessories Market, Segmentation by End User
The Global IV Tubing Sets & Accessories Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers, and Others.
Hospitals
Hospitals dominate the IV tubing sets and accessories market, accounting for nearly 60–65% of the total demand. The segment benefits from a steady flow of surgical procedures, emergency treatments, and chronic care management that require regular intravenous access. Equipped with advanced infrastructure and qualified healthcare professionals, hospitals remain the top users of IV delivery systems globally.
Ambulatory Surgical Centers
Ambulatory Surgical Centers (ASCs) hold approximately 20–25% of the market and continue to grow as a cost-effective alternative to traditional hospitals. These centers are favored for outpatient surgeries and short-duration medical procedures that still require efficient IV fluid or drug administration. The rise in minimally invasive surgeries is accelerating the adoption of IV tubing products in ASCs.
Others
Others, including home healthcare services, nursing facilities, and specialty clinics, make up about 10–15% of the market. This segment is expanding rapidly due to increasing home-based care for elderly and chronically ill patients. The shift toward decentralized care models and the demand for cost-effective treatment solutions are driving growth in these settings.
Global IV Tubing Sets & Accessories Market, Segmentation by Geography
In this report, the Global IV Tubing Sets & Accessories Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global IV Tubing Sets & Accessories Market Share (%), by Geographical Region, 2024
North America
North America dominates the global IV tubing sets and accessories market with an estimated share of 35–40%. This leadership is attributed to a well-established healthcare infrastructure, high levels of medical expenditure, and early adoption of advanced IV technologies. The U.S. is the primary driver, contributing significantly through widespread use in hospital and outpatient settings.
Europe
Europe holds around 25–30% of the market, benefiting from a comprehensive healthcare system and an aging population that requires frequent intravenous therapies. Major economies such as Germany, France, and the UK are seeing rising demand due to increasing surgical volumes and improved chronic disease management.
Asia Pacific
Asia Pacific commands approximately 20–25% of the market and is recognized as the fastest-growing region. Rapid growth in healthcare infrastructure, combined with rising chronic disease incidence and a growing patient population, is propelling demand in countries like India, China, and Japan.
Middle East and Africa
Middle East and Africa account for about 5–8% of the global share. Although the region faces challenges such as limited access in rural areas, ongoing government investments and increasing presence of private hospitals are enhancing market potential and access to IV treatment technologies.
Latin America
Latin America makes up around 5–7% of the global market. Countries like Brazil and Mexico are advancing through improved healthcare infrastructure, growing use of IV therapies, and rising healthcare awareness, contributing to steady market development.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global IV Tubing Sets & Accessories Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers:
- Technological Advancements
- Increasing Chronic Diseases
-
Growing Geriatric Population - The aging population is more susceptible to various medical conditions that necessitate intravenous therapy, such as cardiovascular diseases, cancer, diabetes, and renal disorders, among others. As a result, there is a growing demand for intravenous medications, fluids, and nutrients to manage and treat these chronic ailments effectively. IV tubing sets and accessories play a pivotal role in facilitating the safe and efficient administration of intravenous therapy to elderly patients, ensuring precise delivery of medications and fluids while minimizing the risk of complications or adverse events.
The aging population often presents unique challenges in terms of venous access, vascular fragility, and comorbidities, necessitating specialized intravenous therapy delivery systems tailored to their specific needs. IV tubing sets and accessories designed for geriatric patients prioritize safety, ease of use, and compatibility with fragile veins, ensuring optimal patient comfort and minimizing the risk of vascular injury or infiltration.
The increasing prevalence of age-related conditions such as dehydration, malnutrition, and infections among the elderly contributes to the demand for intravenous therapy solutions, including hydration therapy, nutritional support, and antibiotic administration. IV tubing sets and accessories equipped with advanced features such as antimicrobial filters, anti-kink tubing, and integrated safety mechanisms address these clinical challenges, enhancing the quality of care and treatment outcomes for elderly patients receiving intravenous therapy.
Restraints:
- Stringent Regulatory Requirements
- Limited Healthcare Budgets
-
Concerns Regarding Infections - One of the primary concerns regarding infections in the context of IV tubing sets and accessories is the potential for microbial contamination during manufacturing, storage, handling, or administration processes. Contaminated IV tubing sets and accessories can serve as vehicles for the introduction of pathogens into patients' bloodstream, leading to bloodstream infections and other serious complications. As such, manufacturers and healthcare facilities must adhere to rigorous quality control standards and infection prevention protocols to minimize the risk of contamination and maintain the sterility of IV tubing sets and accessories throughout their lifecycle.
Improper insertion, maintenance, or removal of IV tubing sets and accessories can increase the risk of catheter-related infections, particularly in settings where aseptic techniques are not consistently followed or healthcare personnel lack adequate training or resources. Catheter-related bloodstream infections (CRBSIs) are associated with significant morbidity, mortality, and healthcare costs, underscoring the importance of adherence to evidence-based guidelines for catheter insertion, care, and maintenance to prevent infections and enhance patient safety.
The emergence of antimicrobial-resistant pathogens poses a growing threat to patient health and complicates infection control efforts in healthcare settings. Antimicrobial resistance can limit the effectiveness of standard infection prevention strategies and increase the risk of treatment failure in patients with catheter-related infections. Addressing antimicrobial resistance requires a multifaceted approach, including antimicrobial stewardship initiatives, surveillance programs, and the development of novel infection control technologies to combat resistant pathogens and preserve the efficacy of antimicrobial agents.
Opportunities:
- Expansion in Emerging Markets
- Adoption of Home Healthcare
-
Focus on Patient Safety - One key opportunity lies in the development and adoption of innovative technologies and design features aimed at enhancing patient safety throughout the intravenous therapy process. Manufacturers are increasingly incorporating features such as anti-kink tubing, needleless connectors, air-in-line detectors, and microbial barriers into IV tubing sets and accessories to mitigate the risk of infusion-related complications, including tubing occlusion, air embolism, bloodstream infections, and medication errors. These advancements not only improve the reliability and performance of intravenous infusion systems but also reduce the potential for adverse events and patient harm, thereby enhancing overall patient safety and care quality.
There is a growing emphasis on standardization and best practices in IV therapy administration to minimize errors and ensure consistent, evidence-based approaches to patient care. Healthcare organizations and regulatory bodies are implementing guidelines and protocols for the proper selection, use, and maintenance of IV tubing sets and accessories, as well as for the training of healthcare personnel involved in intravenous therapy administration. By adhering to standardized practices and promoting a culture of safety, healthcare providers can mitigate the risk of errors, enhance medication administration accuracy, and ultimately improve patient outcomes.
Patient education and engagement play a crucial role in promoting safe intravenous therapy practices and empowering patients to actively participate in their care. Healthcare providers can educate patients about the importance of proper IV therapy management, including the recognition of signs of complications, maintenance of catheter hygiene, and adherence to prescribed treatment regimens. Patient-centered communication and shared decision-making foster collaboration between healthcare providers and patients, leading to better treatment adherence, improved patient satisfaction, and ultimately, enhanced patient safety and well-being.
Competitive Landscape Analysis
Key players in Global IV Tubing Sets & Accessories Market include:
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius Kabi AG
- Smiths Medical
- ICU Medical, Inc.
- Nipro Corporation
- Terumo Corporation
- Vygon Group
- Poly Medicure Limited
- Zyno Medical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global IV Tubing Sets & Accessories Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Technological Advancements
-
Increasing Chronic Diseases
-
Growing Geriatric Population
-
- Restraints
-
Stringent Regulatory Requirements
-
Limited Healthcare Budgets
-
Concerns Regarding Infections
-
- Opportunities
-
Expansion in Emerging Markets
-
Adoption of Home Healthcare
-
Focus on Patient Safety
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global IV Tubing Sets & Accessories Market, By Product, 2021 - 2031 (USD Million)
- Primary IV Tubing Sets
- Secondary IV Tubing Sets
- IV Tubing Accessories
- Extension IV Tubing Sets
- Others
- Global IV Tubing Sets & Accessories Market, By Application, 2021 - 2031 (USD Million)
- Central Venous Catheter Placemen
- Peripheral Intravenous Catheter Insertion
- PICC Line Insertion
- Global IV Tubing Sets & Accessories Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Global IV Tubing Sets & Accessories Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global IV Tubing Sets & Accessories Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius Kabi AG
- Smiths Medical
- ICU Medical, Inc.
- Nipro Corporation
- Terumo Corporation
- Vygon Group
- Poly Medicure Limited
- Zyno Medical
- Company Profiles
- Analyst Views
- Future Outlook of the Market